Click on an image to learn more.
| Trade Name | Product Name / Diseases | Manufacturer | Last Label Update | Initial U.S. Approval | Package Insert | Last Approval Letter Update |
|---|---|---|---|---|---|---|
| ACAM2000 | Smallpox (Vaccinia) Vaccine, Live | Emergent Product Development Gaithersburg | March 2018 | 2007 |  | May 2 2017 |
| ActHIB | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | Sanofi Pasteur | 17 May 2019 | 1993 | | May 24 2019 |
| Adacel | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed | Sanofi Pasteur | December 2020 | 2005 | | December 28 2020 |
| Afluria | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus | December 2019 | 2007 | | February 8 2021 |
| Afluria Southern Hemisphere | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus | September 2021 | 2007 | | February 8 2021 |
| Afluria Quadrivalent | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus | March 2021 | 2016 | | July 2 2021 |
| Afluria Quadrivalent Southern Hemisphere | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus | September 2021 | 2016 | | July 2 2021 |
| Agriflu | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus | 10 January 2020 | 2009 | | January 28 2020 |
| AUDENZ | Influenza A (H5N1) Monovalent Vaccine, Adjuvanted | Seqirus | November 2021 | 2020 | | November 17 2021 |
| BCG Vaccine | BCG Vaccine | Organon Teknika Corp | Not indicated in package insert | Not indicated in package insert | | 13 January 2011 |
| Bexsero | Meningococcal Group B Vaccine | Novartis Vaccines and Diagnostics | Not indicated in package insert | 2015 | | January 6 2022 |
| Biothrax | Anthrax Vaccine Adsorbed | Emergent BioDefense Operations Lansing | November 2015 | 1970 | | 23 November 2015 |
| Boostrix | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed | GlaxoSmithKline Biologicals | October 7 2022 | 2005 | | October 7 2022 |
| COMIRNATY (Purple Cap) | COVID-19 Vaccine, mRNA | BioNTech Manufacturing GmbH | December 2021 | 2021 | | December 16 2021 |
| COMIRNATY (Grey Cap) | COVID-19 Vaccine, mRNA | BioNTech Manufacturing GmbH | December 2021 | 2021 | | December 16 2021 |
| Cervarix | Human Papillomavirus Bivalent (Types 16, 18) Vaccine, Recombinant | GlaxoSmithKline Biologicals | Not indicated in package insert | 2009 | | 13 February 2015 |
| Daptacel | Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed | Sanofi Pasteur | Not indicated in package insert | 2002 | | September 16 2016 |
| DENGVAXIA | Dengue Tetravalent Vaccine, Live | Sanofi Pasteur | June 2019 | 2019 | | January 22 2020 |
| Engerix-B | Hepatitis B Vaccine (Recombinant) | GlaxoSmithKline Biologicals | Not indicated in package insert | 1989 | | December 19 2018 |
| ERVEBO | Ebola Zaire Vaccine, Live | Merck Sharp & Dohme Corp | Not indicated in package insert | 2019 | | December 19 2019 |
| FLUAD | Influenza Vaccine, Adjuvanted | Seqirus | November 2015 | October 2020 | | July 2 2021 |
| FLUAD QUADRIVALENT | Influenza Vaccine, Adjuvanted | Seqirus | March 2020 | 2020 | | July 1 2022 |
| Fluarix | Influenza Virus Vaccine (Trivalent, Types A and B) | GlaxoSmithKline Biologicals | Not indicated in package insert | 2005 | | 30 June 2015 |
| Fluarix Quadrivalent | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | Glaxosmithkline Biologicals | 2022 | 2012 | | July 1 2022 |
| Flublok | Influenza Vaccine (Trivalent) | Protein Sciences Corporation | March 2017 | 2013 | | July 7 2017 |
| Flublok Quadrivalent | Influenza Vaccine (Trivalent) | Protein Sciences Corporation | 2022 | 2013 | | July 1 2022 |
| Flucelvax | Influenza Vaccine | Seqirus | April 2016 | 2012 | | August 31 2016 |
| Flucelvax Quadrivalent | Influenza Vaccine | Seqirus | March 2022 | 2016 | | August 31 2016 |
| FluLaval | Influenza Virus Vaccine (Trivalent, Types A and B) | ID Biomedical Corp of Quebec | November 2016 | 2006 | | February 6 2020 |
| FluLaval Quadrivalent | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | ID Biomedical Corporation of Quebec | 2022 | 2013 | | July 2 2020 |
| FluMist | Influenza Vaccine, Live, Intranasal (Trivalent, Types A and B) | MedImmune | July 2015 | 2003 | | July 2 2020 2020 |
| FluMist Quadrivalent | Influenza Vaccine,Live, Intranasal (Quadrivalent, Types A and Types B) | MedImmune | August 2021 | 2003 | | July 27 2022 |
| Fluvirin | Influenza Virus Vaccine (Trivalent, Types A and B) | Seqirus Vaccines | March 2017 | 1988 | | July 7 2017 |
| Fluzone | Influenza Virus Vaccine (Trivalent, Types A and B) | Sanofi Pasteur | 2015 | 1980 | | July 28 2018 |
| Fluzone High-Dose | Influenza Virus Vaccine (Trivalent, Types A and B) | Sanofi Pasteur | 29 March 2019 | 2009 | | July 2 2019 |
| Fluzone Intradermal | Influenza Virus Vaccine (Trivalent, Types A and B) | Sanofi Pasteur | 2 March 2017 | 2014 | | July 2 2019 |
| Fluzone High-Dose Quadrivalent | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | Sanofi Pasteur | July 2022 | 2019 | | July 1 2022 |
| Fluzone Intradermal Quadrivalent | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | Sanofi Pasteur | Not indicated in package inser | 2014 | | July 2 2019 |
| Fluzone Quadrivalent | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | Sanofi Pasteur | July 2022 | 2013 | | July 1 2022 |
| Fluzone Quadrivalent Southern Hemisphere | Influenza Virus Vaccine (Quadrivalent, Types A and Types B) | Sanofi Pasteur | 2021 | 2013 | | February 14 2022 |
| Gardasil | Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant | Merck & Co. | April 2015 | 2006 | | 24 April 2015 |
| Gardasil 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | Merck & Co. | August 2020 | 2014 | | August 20 2020 |
| Havrix | Hepatitis A Vaccine, Inactivated | GlaxoSmithKline Biologicals | Not indicated in package insert | 1995 | | December 19 2018 |
| HEPLISAV-B | Hepatitis B Vaccine (Recombinant), Adjuvanted | Dynavax Technologies Corporation | 05 May 2020 | 2017 | | May 6 2020 |
| HIBERIX | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | GlaxoSmithKline Biologicals | April 2018 | 2009 | | December 19 2018 |
| Imovax | Rabies Vaccine | Sanofi Pasteur | October 2019 | Not indicated in package insert | | October 25 2019 |
| Infanrix | Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed | GlaxoSmithKline Biologicals | Not indicated in package insert | 1997 | | November 6 2019 |
| IPOL | Poliovirus Vaccine Inactivated (Monkey Kidney Cell) | Sanofi Pasteur | Not indicated in package insert | Not indicated in package insert | | June 2 2022 |
| Ixiaro | Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed | Valneva | September 2018 | 2009 | | October 4 2018 |
| JE-Vax | Japanese Encephalitis Virus Vaccine Inactivated | Research Foundation for Microbial Diseases of Osaka University | December 2005 | Not indicated in package insert | | Not indicated |
| JYNNEOS | Smallpox and Monkeypox Vaccine, Live, Non-Replicating | Bavarian Nordic | April 2022 | 2019 | | June 16 2021 |
| Kinrix | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | GlaxoSmithKline Biologicals | Not indicated in package insert | 2008 | | November 6 2019 |
| M-M-R II | Measles, Mumps, and Rubella Virus Vaccine, Live | Merck & Co. | Not indicated in package insert | 1978 | | December 11 2020 |
| Menactra | Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine | Sanofi Pasteur | 26 April 2018 | 2005 | | April 27 2018 |
| MenHibrix | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | GlaxoSmithKline Biologicals | Not indicated in package insert | 2012 | | 27 November 2013 |
| Menomune-A/C/Y/W-135 | Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined | Sanofi Pasteur | 14 March 2016 | 1981 | | 3 October 2013 |
| MenQuadfi | Meningococcal (Groups A, C, Y, W) Conjugate Vaccine | Sanofi Pasteur | October 2021 | 2020 | | June 16 2022 |
| Menveo | Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine | GlaxoSmithKline Biologicals | July 2020 | 2010 | | April 27 2018 |
| None | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral | Barr Labs | October 2019 | 2011 | | October 15 2019 |
| None | Diphtheria and Tetanus Toxoids Adsorbed | Sanofi Pasteur | June 2018 | 1997 | | June 6 2018 |
| None | Influenza A (H1N1) 2009 Monovalent Vaccine | CSL | November 2009 | 2007 | | 10 November 2009 |
| None | Influenza A (H1N1) 2009 Monovalent Vaccine | MedImmune | Not indicated in package insert | 2003 | | 3 February 2010 |
| None | Influenza A (H1N1) 2009 Monovalent Vaccine | ID Biomedical Corporation of Quebec | January 2010 | 2006 | | 10 November 2009 |
| None | Influenza A (H1N1) 2009 Monovalent Vaccine | Novartis Vaccines and Diagnostics | September 2009 | Not indicated in package insert | | 15 September 2009 |
| None | Influenza A (H1N1) 2009 Monovalent Vaccine | Sanofi Pasteur | 10 September 2009 | 1980 | | September 15 2009 |
| None | Influenza Virus Vaccine, H5N1 (for National Stockpile) | Sanofi Pasteur | April 2007 | 2007 | | 17 April 2007 |
| None | Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | ID Biomedical Corporation of Quebec | Not indicated in package insert | 2013 | | 22 November 2013 |
| None | Diphtheria & Tetanus Toxoids Adsorbed | Sanofi Pasteur | December 2005 | Not indicated in package insert | | 29 December 2003 |
| None | Tetanus Toxoid Adsorbed | Sanofi Pasteur | June 2018 | 1997 | | December 20 2018 |
| Pediarix | Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed, Hepatitis B (recombinant) and Inactivated Poliovirus Vaccine Combined | GlaxoSmithKline Biologicals | Not indicated in package insert | 2002 | | November 6 2019 |
| Liquid PedvaxHIB | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) | Merck & Co. | 1998 | Not indicated in package insert | | 27 April 2011 |
| Pentacel - (inactivated poliovirus component grown in MRC-5 cells) | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine | Sanofi Pasteur | February 2021 | 2008 | | February 17 2021 |
| Pentacel - (inactivated poliovirus component grown in Vero cells) | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine | Sanofi Pasteur | December 2019 | 2008 | | February 17 2021 |
| Pneumovax 23 | Pneumococcal Vaccine, Polyvalent | Merck Sharp & Dohme Corp | April 2021 | 1983 | | October 27 2021 |
| PREHEVBRIO | Hepatitis B Vaccine (Recombinant) | VBI Vaccines (Delaware) Inc | Not indicated in package insert | Not indicated in package insert | | November 30 2021 |
| Prevnar 13 | Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) | Wyeth Pharmaceuticals | 2017 | 2010 | | August 22 2017 |
| PREVNAR 20 | Pneumococcal 20-valent Conjugate Vaccine | Wyeth Pharmaceuticals | September 2022 | 2021 | | September 30 2022 |
| PRIORIX | Pneumococcal 20-valent Conjugate Vaccine | GlaxoSmithKline Biologicals | June 2022 | 2022 | | June 3 2022 |
| ProQuad (Frozen) | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Merck Sharpe & Dohme Corp | April 2021 | 2005 | | April 13 2021 |
| ProQuad (Frozen Formulation - Recombinant Human Albumin (RHA)) | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Merck Sharpe & Dohme Corp | Not indicated in package insert | 2005 | | September 15 2020 |
| ProQuad (Frozen Formulation - Human Serum Albumin (HSA)) | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Merck Sharpe & Dohme Corp | Not indicated in package insert | 2005 | | September 15 2020 |
| ProQuad (Refrigerated) | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Merck Sharpe & Dohme Corp | April 2021 | 2005 | | April 13 2021 |
| ProQuad (Refrigerator-Stable Formulation) | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Merck Sharpe & Dohme Corp | October 2018 | 2005 | | April 13 2021 |
| Quadracel (inactivated poliovirus component grown in MRC-5 cells) | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | Sanofi Pasteur | February 2021 | 2015 | | February 17 2021 |
| Quadracel (inactivated poliovirus component grown in Vero cells) | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | Sanofi Pasteur | December 2019 | 2015 | | February 17 2021 |
| RabAvert | Rabies Vaccine | Novartis Vaccines and Diagnostics | Not indicated in package insert | Not indicated in package insert | | August 3 2018 |
| Recombivax HB | Hepatitis B Vaccine (Recombinant) | Merck & Co. | December 2018 | 1986 | | December 21 2018 |
| ROTARIX | Rotavirus Vaccine, Live, Oral | GlaxoSmithKline Biologicals | Not indicated in package insert | 2008 | | November 21 2019 |
| RotaTeq | Rotavirus Vaccine, Live, Oral, Pentavalent | Merck & Co. | August 2020 | 2006 | | August 14 2020 |
| SHINGRIX | Zoster Vaccine Recombinant, Adjuvanted | GlaxoSmithKline Biologicals | July 2021 | 2017 | | July 23 2021 |
| SPIKEVAX | COVID-19 Vaccine, mRNA | Moderna US | January 2022 | 2022 | | January 31 2022 |
| TDVAX (NDC 14362-0111) | Tetanus & Diphtheria Toxoids, Adsorbed | MassBiologics | Not indicated in package insert | September 2018 | | January 31 2022 |
| TDVAX (NDC 13533-131) | Tetanus & Diphtheria Toxoids, Adsorbed | MassBiologics | Not indicated in package insert | September 2018 | | January 31 2022 |
| Tenivac | Tetanus & Diphtheria Toxoids Adsorbed for Adult Use | Sanofi Pasteur | November 2019 | 2003 |  | December 6 2019 |
| TICE BCG | BCG Live | Organon Teknika Corp | February 2009 | Not indicated in package insert | | 16 December 2010 |
| TICOVAC | BCG Live | Pfizer | Not indicated in package insert | Not indicated in package insert | | August 13 2021 |
| Trumenba | Meningococcal Group B Vaccine | Wyeth Pharmaceuticals | 2018 | 2014 | | November 19 2021 |
| Twinrix | Hepatitis A Inactivated and Hepatitis B (Recombinant) Vaccine | GlaxoSmithKline Biologicals | March 2015 | 2001 | | December 18 2018 |
| Typhim Vi | Typhoid Vi Polysaccharide Vaccine | Sanofi Pasteur | March 2020 | Not indicated in package insert | | March 20 2020 |
| VAQTA | Hepatitis A Vaccine, Inactivated | Merck & Co. | Not indicated in package insert | 1996 | | October 23, 2020 |
| Varivax (Frozen) | Varicella Virus Vaccine Live | Merck Shark & Dohme Corp. | September 2020 | 1995 | | September 15, 2020 |
| Varivax (Refrigerator) | Varicella Virus Vaccine Live | Merck & Co. | 2013 | 1995 | | 28 March 2014 |
| Vaxchora (Frozen) | Cholera Vaccine Live Oral | PaxVax Bermuda Ltd | Not indicated in package insert | 2016 | | Not indicated |
| Vaxchora | Cholera Vaccine Live Oral | Emergent Travel Health Inc | December 2022 | 2016 | | December 12 2022 |
| VAXELIS | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine | MSP Vaccine Company | October 2020 | 2018 | | January 31 2022 |
| VAXNEUVANCE | Pneumococcal 15-valent Conjugate Vaccine | Merck Sharp & Dohme Corp | Not indicated in package insert | 2021 | | July 17 2022 |
| Vivotif | Typhoid Vaccine Live Oral Ty21a | Berna Biotech | September 2013 | Not indicated in package insert | | Not indicated |
| YF-Vax | Yellow Fever Vaccine | Sanofi Pasteur | February 2019 | Not indicated in package insert | | July 16 2021 |
| Zostavax (Refrigerator Stable) | Zoster Vaccine, Live, (Oka/Merck) | Merck & Co. | August 2018 | 2006 | | February 21 2019 |
| Zostavax (Frozen) | Zoster Vaccine, Live, (Oka/Merck) | Merck & Co. | January 2019 | 2006 | | February 21 2019 |
| Trade Name | Product Name / Diseases | Manufacturer | Last Label Update | First Published | Package Insert |
|---|---|---|---|---|---|
| Adjupanrix | Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | GlaxoSmithKline Biologicals | 08/06/2022 | 17/12/2009 | |
| Aflunov | zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | Seqirus | 03/10/2022 | 24/01/2011 | |
| Ambirix | Hepatitis-A (inactivated) and hepatitis-B (rDNA) (HAB) vaccine (adsorbed) | GlaxoSmithKline Biologicals | 14/01/2022 | 24/09/2007 | |
| Aptivus | HIV Infections | Boehringer Ingelheim International | 23/08/2022 | 17/12/2009 | |
| Atazanavir Krka | HIV Infections | Krka | 09/12/2021 | 15/05/2019 | |
| Atazanavir Mylan | HIV Infections | Mylan Pharmaceuticals | 26/09/2022 | 31/01/2017 | |
| Baraclude | Hepatitis B, Chronic | Bristol-Myers Squibb | 15/06/2022 | 13/10/2009 | |
| Bexsero | Meningitis, Meningococcal | GSK Vaccines | 12/10/2022 | 28/01/2012 | |
| Biktarvy | HIV Infections | Gilead Sciences | 20/07/2022 | 22/06/2018 | |
| Celsentri | HIV Infections | ViiV Healthcare | 22/08/2022 | 11/8/2009 | |
| Cervarix | Immunization; Papillomavirus Infections; Uterine Cervical Dysplasia | GlaxoSmithKline Biologicals | 03/11/2021 | 02/12/2009 | |
| Combivir | HIV Infections | ViiV Healthcare | 29/08/2022 | 28/04/2009 | |
| Darunavir Krka | HIV Infections | KRKA | 21/12/2021 | 06/02/2018 | |
| Darunavir Krka d.d. | HIV Infections | KRKA | 21/12/2021 | 25/01/2018 | |
| Darunavir Mylan | HIV Infections | Mylan Pharmaceuticals | 18/01/2022 | 03/02/2017 | |
| Delstrigo | HIV Infections | Merck Sharp & Dohme | 11/10/2022 | 10/01/2019 | |
| Dengvaxia | Dengue | Sanofi Pasteur | 26/01/2022 | 18/12/2018 | |
| Dificlir | Clostridium Infections | Tillotts Pharma | 07/03/2022 | 19/12/2011 | |
| Dovato | HIV Infections | ViiV Healthcare | 05/09/2022 | 04/09/2019 | |
| Dukoral | Cholera; Immunization | Valneva Sweden | 06/04/2022 | 04/05/2009 | |
| Ebilfumin | Influenza, Human | Actavis Group | 08/12/2021 | 06/06/2014 | |
| Edurant | HIV Infections | Janssen-Cilag | 15/09/2021 | 12/12/2011 | |
| Efavirenz Teva | HIV Infections | Teva | 10/02/2022 | 27/01/2012 | |
| Emtriva | HIV Infections | Gilead Sciences | 31/05/2021 | 09/07/2009 | |
| Entecavir Accord | Hepatitis B, Chronic | Accord Healthcare | 29/07/2022 | 26/01/2018 | |
| Entecavir Mylan | Hepatitis B | Mylan Pharmaceuticals | 29/07/2022 | 10/10/2017 | |
| Epclusa | Hepatitis C, Chronic | Gilead Sciences | 18/01/2022 | 28/07/2016 | |
| Epivir | HIV Infections | ViiV Healthcare | 29/08/2022 | 02/12/2009 | |
| Ervebo | Hemorrhagic Fever, Ebola | Merck Sharp & Dohme | 04/08/2022 | 12/12/2019 | |
| Eviplera | HIV Infections | Gilead Sciences | 11/08/2021 | 12/12/2011 | |
| Evotaz | HIV Infections | Bristol-Myers Squibb | 18/02/2022 | 10/08/2015 | |
| Exviera | Hepatitis C, Chronic | AbbVie | 12/08/2022 | 12/02/2015 | |
| Fendrix | Hepatitis B; Immunization | GlaxoSmithKline Biologicals | 14/01/2022 | 07/04/2009 | |
| Fluad Tetra | Influenza, Human | Seqirus | 01/08/2022 | 29/05/2020 | |
| Flucelvax Tetra | Influenza, Human | Seqirus | 01/08/2022 | 19/10/2018 | |
| Fluenz Tetra | Influenza, Human | MedImmune | 01/08/2022 | 17/12/2013 | |
| Foclivia | Disease Outbreaks; Immunization; Influenza, Human | Seqirus | 06/04/2022 | 17/12/2009 | |
| Fuzeon | HIV Infections | Roche Registration | 24/11/2021 | 24/10/2008 | |
| Gardasil | Condylomata Acuminata; Immunization; Papillomavirus Infections; Uterine Cervical Dysplasia | Merck Sharp & Dohme | 06/07/2022 | 25/09/2009 | |
| Gardasil 9 | Condylomata; Acuminata; Immunization; Papillomavirus Infections Uterine Cervical Dysplasia | Merck Sharp & Dohme | 06/07/2022 | 03/07/2015 | |
| Genvoya | HIV Infections | Gilead Sciences | 02/09/2022 | 01/12/2015 | |
| Granupas (previously Para-aminosalicylic acid Lucane) | Tuberculosis | Eurocept International | 11/10/2022 | 12/05/2014 | |
| Harvoni | Hepatitis C, Chronic | Gilead Sciences | 06/07/2022 | 04/12/2014 | |
| HBVaxPro | Hepatitis B; Immunization | Merck Sharp & Dohme | 16/08/2022 | 20/02/2008 | |
| Heplisav B | Hepatitis B | Dynavax | 11/01/2022 | 01/03/2021 | |
| Hepsera | Hepatitis B, Chronic | Gilead Sciences | 06/05/2021 | 09/07/2009 | |
| Hexacima | Diphtheria; Hepatitis ; Immunization; Meningitis; Haemophilus; Poliomyelitis; Tetanus; Whooping Cough | Sanofi Pasteur | 12/05/2022 | 12/07/2013 | |
| Hexyon | Diphtheria Hepatitis B; Immunization; Meningitis, Haemophilus; Poliomyelitis; Tetanus; Whooping Cough | Sanofi Pasteur | 12/05/2022 | 12/07/2013 | |
| Imvanex | Smallpox | Bavarian Nordic | 25/07/2022 | 16/08/2013 | |
| Infanrix Hexa | Diphtheria; Hepatitis B; Immunization; Meningitis, Haemophilus; Poliomyelitis; Tetanus; Whooping Cough | GlaxoSmithKline Biologicals s.a. | 11/05/2022 | 26/11/2008 | |
| Intelence | HIV Infections | Janssen-Cilag | 12/05/2021 | 07/08/2009 | |
| IntronA | Carcinoid Tumor; Hepatitis B, Chronic; Hepatitis C, Chronic; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Follicular; Melanoma; Multiple Myeloma | Merck Sharp & Dohme | 06/07/2021 | 01/04/2009 | |
| Invanz | Community-Acquired Infections; Gram-Negative Bacterial Infections; Pneumonia, Bacterial; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection | Merck Sharp & Dohme | 09/02/2022 | 28/10/2009 | |
| Invirase | HIV Infections | Roche Registration | 25/11/2021 | 08/04/2009 | |
| Isentress | HIV Infections | Merck Sharp & Dohme | 29/11/2021 | 18/09/2009 | |
| Ixiaro | Encephalitis, Japanese; Immunization | Valneva Austria | 12/04/2021 | 06/05/2009 | |
| Jcovden (previously COVID-19 Vaccine Janssen) | COVID-19 virus infection | Janssen-Cilag | 18/07/2022 | 11/03/2021 | |
| Juluca | HIV Infections | ViiV Healthcare | 05/09/2022 | 24/05/2018 | |
| Kaletra | HIV Infections | AbbVie Deutschland | 13/10/2022 | 23/09/2009 | |
| Kivexa | HIV Infections | ViiV Healthcare | 23/08/2022 | 16/07/2007 | |
| Lamivudine Teva | Hepatitis B, Chronic | Teva | 06/01/2022 | 09/11/2009 | |
| Lamivudine Teva Pharma B.V. | HIV Infections | Teva | 18/01/2022 | 16/12/2009 | |
| Lamivudine/Zidovudine Teva | HIV Infections | Teva Pharma | 25/03/2022 | 15/03/2011 | |
| Lopinavir/Ritonavir Mylan | HIV Infections | Mylan Pharmaceuticals | 09/06/2022 | 09/02/2016 | |
| Maviret | Hepatitis C, Chronic | AbbVie Deutschland | 23/08/2022 | 17/08/2017 | |
| MenQuadfi | Meningitis, Meningococcal | Sanofi Pasteur | 19/05/2022 | 27/11/2020 | |
| Menveo | Immunization; Meningitis, Meningococcal | GSK Vaccines | 18/01/2022 | 04/05/2010 | |
| M-M-RVAXPRO | Immunization; Measles; Mumps; Rubella | Merck Sharp & Dohme | 14/07/2022 | 04/08/2008 | |
| Mvabea | Hemorrhagic Fever, Ebola | Janssen-Cilag | 10/01/2022 | 23/07/2020 | |
| Nevirapine Teva | HIV Infections | Teva | 09/12/2021 | 14/12/2009 | |
| Nimenrix | Meningitis, Meningococcal | Pfizer Europe | 25/05/2022 | 24/05/2012 | |
| Norvir | HIV Infections | AbbVie Deutschland | 25/08/2022 | 15/11/2009 | |
| Nuvaxovid | COVID-19 virus infection | Novavax CZ | 12/10/2022 | 20/12/2021 | |
| Odefsey | HIV Infections | Gilead Sciences | 10/06/2021 | 08/07/2016 | |
| Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) | Influenza, Human | AstraZeneca | 06/10/2022 | 02/06/2016 | |
| Pandemic Influenza Vaccine H5N1 Baxter AG | Influenza, Human; Immunization; Disease Outbreaks | Ology Bioservices | 26/04/2022 | 17/12/2009 | |
| Pegasys | Hepatitis B, Chronic; Hepatitis C, Chronic | zr pharma | 05/01/2022 | 16/11/2009 | |
| Pifeltro | HIV Infections | Merck Sharp & Dohme | 23/08/2021 | 10/01/2019 | |
| Prevenar 13 | Immunization; Pneumococcal Infections | Pfizer Europe | 26/10/2021 | 08/01/2010 | |
| Prezista | HIV Infections | Janssen-Cilag | 17/08/2022 | 05/11/2009 | |
| ProQuad | Chickenpox; Immunization; Measles; Mumps; Rubella | Merck Sharp & Dohme | 22/07/2022 | 12/08/2009 | |
| Rebetol | Hepatitis C, Chronic | Merck Sharp and Dohme | 13/12/2021 | 22/10/2009 | |
| Rekambys | HIV Infections | Janssen-Cilag International | 12/10/2022 | 04/01/2021 | |
| Reyataz | HIV Infections | Bristol-Myers Squibb | 18/02/2022 | 15/12/2009 | |
| Rezolsta | HIV Infections | Janssen-Cilag International | 03/08/2022 | 12/12/2014 | |
| Rotarix | Immunization; Rotavirus Infections | GlaxoSmithKline Biologicals | 05/04/2022 | 05/10/2009 | |
| RotaTeq | Immunization; Rotavirus Infections | Merck Sharp & Dohme | 16/08/2022 | 04/12/2009 | |
| Rukobia | HIV Infections | ViiV Healthcare | 22/08/2022 | 12/02/2021 | |
| Shingrix | Herpes Zoster | GlaxoSmithkline Biologicals | 13/10/2021 | 28/03/2018 | |
| Sirturo | Tuberculosis, Multidrug-Resistant | Janssen-Cilag International | 23/11/2021 | 14/03/2014 | |
| Sovaldi | Hepatitis C, Chronic | Gilead Sciences | 22/08/2022 | 05/02/2014 | |
| Spikevax (previously COVID-19 Vaccine Moderna) | COVID-19 virus infection | Moderna Biotech Spain | 05/10/2022 | 20/01/2021 | |
| Stocrin | HIV InfectionsHIV Infections | Merck Sharp & Dohme | 05/10/2022 | 13/01/2010 | |
| Stribild | HIV Infections | Gilead Sciences | 13/10/2021 | 13/06/2013 | |
| Supemtek | Influenza, Human | Sanofi Pasteur | 28/07/2022 | 25/11/2020 | |
| Sustiva | HIV Infections | Bristol-Myers Squibb | 17/10/2022 | 16/11/2009 | |
| Symtuza | HIV Infections | Janssen-Cilag | 08/09/2022 | 26/09/2017 | |
| Synflorix | Immunization; Pneumococcal Infections | GlaxoSmithKline Biologicals | 26/08/2022 | 08/07/2009 | |
| Tamiflu | Influenza, Human | Roche Registration | 25/11/2021 | 01/12/2009 | |
| Tecovirimat SIGA | Poxviridae Infections; Cowpox; Monkeypox; Vaccinia; Smallpox | SIGA Technologies Netherlands | Not stated in the package insert | 28/01/2022 | |
| Telzir | HIV Infections | ViiV Healthcare | 23/08/2022 | 16/12/2009 | |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | HIV Infections | KRKA | 24/05/2022 | 20/02/2018 | |
| Tenofovir disoproxil Mylan | HIV Infections | Mylan | 30/08/2022 | 19/12/2016 | |
| Tenofovir disoproxil Zentiva | HIV Infections | Zentiva | 15/09/2022 | 13/03/2017 | |
| Tivicay | HIV Infections | ViiV Healthcare | 05/09/2022 | 05/02/2014 | |
| Triumeq | HIV Infections | ViiV Healthcare | 05/09/2022 | 15/10/2014 | |
| Trizivir | HIV Infections | ViiV Healthcare | 29/08/2022 | 09/12/2009 | |
| Trogarzo | HIV Infections | Theratechnologies Europe | 17/10/2022 | 10/10/2019 | |
| Trumenba | Meningitis, Meningococcal | Pfizer Europe | 24/05/2022 | 06/06/2017 | |
| Truvada | HIV Infections | Gilead Sciences | 31/05/2021 | 11/06/2009 | |
| Twinrix Adult | Hepatitis A; Hepatitis B; Immunization | GlaxoSmithKline Biologicals | 14/01/2022 | 09/07/2008 | |
| Twinrix Paediatric | Hepatitis A; Hepatitis B; Immunization | GlaxoSmithKline Biologicals | 14/01/2022 | 09/07/2008 | |
| Tybost | HIV Infections | Gilead Sciences | 13/10/2021 | 24/10/2013 | |
| Vaxchora | Cholera | Emergent Netherlands | 27/09/2022 | 08/04/2020 | |
| Vaxelis | Diphtheria Hepatitis B Meningitis, Haemophilus Poliomyelitis Tetanus Whooping Cough | MCM Vaccine | 11/10/2022 | 26/02/2016 | |
| Vaxneuvance | Pneumococcal Infections | Merck Sharp & Dohme | 25/04/2022 | 17/01/2022 | |
| Vaxzevria (previously COVID-19 Vaccine AstraZeneca) | COVID-19 virus infection | AstraZeneca | 12/10/2022 | 18/02/2021 | |
| Vemlidy | Hepatitis B | Gilead Sciences | 05/09/2022 | 10/03/2017 | |
| Viekirax | Hepatitis C, Chronic | AbbVie Deutschland | 12/08/2022 | 09/03/2015 |
|
| ViraferonPeg | Hepatitis C, Chronic | Merck Sharp Dohme | 22/01/2021 | 17/09/2009 |
|
| Viramune | HIV Infections | Boehringer Ingelheim International | 23/08/2022 | 11/06/2009 |
|
| Viread | HIV Infections; Hepatitis B, Chronic | Gilead Sciences | 22/03/2022 | 03/08/2009 |
|
| Vocabria | HIV Infections | ViiV Healthcare | 22/08/2022 | 05/01/2021 |
|
| Vosevi | Hepatitis C, Chronic | Gilead Sciences | 07/07/2022 | 22/09/2017 |
|
| Xevudy | COVID-19 virus infection | GlaxoSmithKline Trading Services | 17/10/2022 | 16/12/2021 |
|
| Zabdeno | Hemorrhagic Fever, Ebola | Janssen-Cilag International | 05/01/2022 | 23/07/2020 |
|
| Zeffix | Hepatitis B, Chronic | GlaxoSmithKline (Ireland) | 19/07/2022 | 02/09/2009 |
|
| Ziagen | HIV Infections | ViiV Healthcare | 29/08/2022 | 12/12/2009 |
|
| Zinforo | Community-Acquired Infections; Pneumonia; Skin Diseases, Infectious | Pfizer Ireland | 22/07/2022 | 18/09/2012 |
|
| Zostavax | Herpes Zoster; Immunization | Merck Sharp & Dohme | 01/07/2022 | 14/12/2009 |
|
| Zutectra | Hepatitis B; Immunization, Passive; Liver Transplantation | Biotest Pharma | 22/08/2019 | 12/02/2010 | |
| Trade Name | Type | Presentation | Manufacturer | Responsible NRA | "Prequalified" | Package Insert |
|---|---|---|---|---|---|---|
| - | Yellow Fever | Ampoule | Federal State Budgetary Scientific Institution «Chumakov Federal Scientific Center for Research & Development of Immune-And Biological Products», Russian Academy of Sciences | Federal Service on Surveillance in Healthcare (ROSZDRAVNADZOR) of the Russian Federation | 26/03/2009 | |
| AGRIFLU | Influenza, seasonal (Trivalent) | Vial | Seqirus Vaccines Limited | Health Canada - Santé Canada | 23/12/2016 | |
| Act-HIB | Haemophilus influenzae type b | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 01/04/1998 | |
| Adacel | Diphtheria-Tetanus-Pertussis (acellular) | Vial | Sanofi Pasteur Limited | Health Canada - Santé Canada | 08/05/2017 | |
| Adsorbed DT Vaccine | Diphtheria-Tetanus | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 11/03/1999 | |
| Afluria® | Influenza, seasonal (Trivalent) | Vial | Seqirus Limited | US Food and Drug Administration- Office of Vaccine Research and Review | 07/02/2020 | |
| Afluria® Quadrivalent | Influenza, seasonal (Quadrivalent) | Vial | Seqirus Limited | US Food and Drug Administration- Office of Vaccine Research and Review | 05/03/2019 | |
| BCG Freeze Dried Glutamate vaccine | BCG | Ampoule | Japan BCG Laboratory | Pharmaceutical and Medical Devices Agency | 01/01/1987 | |
| BCG Vaccine | BCG | Ampoule | BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.) | Bulgarian Drug Agency | 01/02/1991 | |
| BCG Vaccine | BCG | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 29/05/2003 | |
| BCG Vaccine AJV | BCG | Two vial set (active + excipient) | AJ Vaccines A/S | Danish Medicines Agency | 27/09/1994 | |
| BIOPOLIO | Polio Vaccine - Oral (OPV) Trivalent | Vial | Bharat Biotech International Limited | Central Drugs Standard Control Organization | 20/03/2015 | |
| BIOPOLIO B1/3 | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Bharat Biotech International Limited | Central Drugs Standard Control Organization | 20/03/2015 | |
| Bivalent OPV Type 1 and 3 Poliomyelitis Vaccine, Live (Oral) | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Panacea Biotec Ltd. | Central Drugs Standard Control Organization | 16/11/2021 | |
| Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3) | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 26/05/2010 | |
| Bivalent type 1&3 Oral Poliomyelitis vaccine, IP (bOPV1&3) | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Haffkine Bio Pharmaceutical Corporation Ltd | Central Drugs Standard Control Organization | 19/03/2010 | |
| Boostrix | Diphtheria-Tetanus-Pertussis (acellular) | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 09/07/2013 | |
| Cecolin® | Human Papillomavirus (Bivalent) | Vial | Xiamen Innovax Biotech Co. Ltd. | National Medical Products Administration | 14/10/2021 | |
| Celtura | Influenza, Pandemic (H1N1) | Vial | Seqirus GmbH | Paul-Ehrlich-Institut | 17/12/2009 | |
| Cervarix | Human Papillomavirus (Bivalent) | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 08/07/2009 | |
| DTP Vaccine | Diphtheria-Tetanus-Pertussis (whole cell) | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 06/04/2001 | |
| Dengvaxia | Dengue Tetravalent (live, attenuated) | Two vial set (active + excipient) | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 25/03/2020 | |
| Diftet | Diphtheria-Tetanus | Vial | BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.) | Bulgarian Drug Agency | 09/05/2006 | |
| Diphtheria ,Tetanus, Pertussis and Hepatitis B Vaccine Adsorbed | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B | Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 21/07/2006 | |
| Diphtheria ,Tetanus, Pertussis and Hepatitis B Vaccine Adsorbed | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 21/07/2006 | |
| Diphtheria and Tetanus Vaccine Adsorbed (Pediatric) | Diphtheria-Tetanus | Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Diphtheria and Tetanus Vaccine Adsorbed (Pediatric) | Diphtheria-Tetanus | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents | Diphtheria-Tetanus (reduced antigen content) | Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents | Diphtheria-Tetanus (reduced antigen content) | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Diphtheria, Tetanus, Pertussis and Haemophilus influenzae type b Conjugate Vaccine | Diphtheria-Tetanus-Pertussis (whole cell)-Haemophilus influenzae type b | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 23/06/2010 | |
| Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 26/05/2010 | |
| Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 22/09/2010 | |
| Diphtheria-Tetanus-Pertussis Vaccine Adsorbed | Diphtheria-Tetanus-Pertussis (whole cell) | Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Diphtheria-Tetanus-Pertussis Vaccine Adsorbed | Diphtheria-Tetanus-Pertussis (whole cell) | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Dukoral | cholera: inactivated oral | Vial + Buffer Sachet | Valneva Sweden AB | Medical Products Agency | 25/10/2001 | |
| ERVEBO | Ebola Zaire (rVSV∆G-ZEBOV-GP, live attenuated) | Vial | Merck Vaccines | European Medicines Agency | 12/11/2019 | |
| Easyfive-TT | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | Panacea Biotec Ltd. | Central Drugs Standard Control Organization | 02/10/2013 | |
| Engerix | Hepatitis B | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 01/01/1987 | - |
| Eupenta | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | LG Chem Ltd | Ministry of Food and Drug Safety | 10/02/2016 | |
| Eupolio Inj. | Polio Vaccine - Inactivated Sabin (sIPV) | Vial | LG Chem Ltd | Ministry of Food and Drug Safety | 01/06/2021 | |
| Euvax B | Hepatitis B | Vial | LG Chem Ltd | Ministry of Food and Drug Safety | 22/11/1996 | |
| Euvax B | Hepatitis B | Vial | LG Chem Ltd | Ministry of Food and Drug Safety | 22/11/1996 | |
| Euvax B | Hepatitis B (Paediatric) | Vial | LG Chem Ltd | Ministry of Food and Drug Safety | 21/01/2020 | |
| Euvichol | cholera: inactivated oral | Vial | EuBiologics Co., Ltd. | Ministry of Food and Drug Safety | 23/12/2015 | |
| Euvichol-Plus | cholera: inactivated oral | Plastic Tube | EuBiologics Co., Ltd. | Ministry of Food and Drug Safety | 11/08/2017 | |
| Fluvirin | Influenza, seasonal (Trivalent) | Vial | Seqirus Vaccines Limited | CBER/FDA | 09/12/2009 | - |
| Fluvirin-H1N1 | Influenza, Pandemic (H1N1) | Vial | Seqirus Vaccines Limited | CBER/FDA | 09/12/2009 | |
| Fluzone | Influenza, seasonal (Trivalent) | Vial | Sanofi Pasteur Inc. | CBER/FDA | 21/01/2010 | |
| Fluzone Quadrivalent | Influenza, seasonal (Quadrivalent) | Vial | Sanofi Pasteur Inc. | US Food and Drug Administration- Office of Vaccine Research and Review | 04/11/2015 | - |
| Focetria | Influenza, Pandemic (H1N1) | Vial | Seqirus Vaccines Limited | 16/12/2009 | |
|
| GC FLU inj | Influenza, seasonal (Trivalent) | Vial | Green Cross Corporation | Ministry of Food and Drug Safety | 12/04/2011 | |
| GC FLU Multi inj. | Influenza, seasonal (Trivalent) | Vial | Green Cross Corporation | Ministry of Food and Drug Safety | 07/11/2012 | |
| GCFLU Quadrivalent Multi inj. | Influenza, seasonal (Quadrivalent) | Vial | Green Cross Corporation | Ministry of Food and Drug Safety | 03/04/2017 | |
| GCFLU Quadrivalent inj. | Influenza, seasonal (Quadrivalent) | Vial | Green Cross Corporation | Ministry of Food and Drug Safety | 21/12/2016 | |
| Gardasil | Human Papillomavirus (Quadrivalent) | Vial | Merck Vaccines | European Medicines Agency | 20/05/2009 | |
| Gardasil 9 | Human Papillomavirus (Ninevalent) | Vial | Merck Vaccines | European Medicines Agency | 09/02/2018 | |
| Green Flu-S | Influenza, Pandemic (H1N1) | Vial | Green Cross Corporation | Ministry of Food and Drug Safety | 11/05/2010 | |
| HEALIVE | Hepatitis A (Human Diploid Cell), Inactivated (Adult) | Vial | Sinovac Biotech Co. Ltd | National Medical Products Administration | 22/12/2017 | |
| Haemophilus influenzae type b Conjugate Vaccine | Haemophilus influenzae type b | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 17/11/2008 | |
| Havrix 1440 Adult | Hepatitis A (Human Diploid Cell), Inactivated (Adult) | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 19/07/2013 | |
| Havrix 720 Junior | Hepatitis A (Human Diploid Cell), Inactivated (Paediatric) | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 19/07/2013 | |
| Heberbiovac HB | Hepatitis B | Vial | Centro de Ingenieria Genetica y Biotecnologia | Centro para el Control Estatal de la Calidad de los Medicamentos | 11/12/2001 | |
| Hepatitis B Vaccine (rDNA) (Adult) | Hepatitis B | Ampoule or Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 12/11/2004 | |
| Hepatitis B Vaccine (rDNA) (Paediatric) | Hepatitis B | Ampoule or Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 12/11/2004 | |
| Hexaxim | Diphtheria-Tetanus-Pertussis (acellular)-Hepatitis B-Haemophilus influenzae type b-Polio (Inactivated) | Vial | Sanofi Pasteur | European Medicines Agency | 19/12/2014 | |
| IL-YANG FLU Vaccine INJ. | Influenza, seasonal (Trivalent) | Vial | IL-YANG PHARMACEUTICAL CO., LTD. | Ministry of Food and Drug Safety | 25/05/2018 | - |
| IMOJEV MD | Japanese Encephalitis Vaccine (live, attenuated) | Two vial set (active + excipient) | GPO-MBP Co., Ltd. | Thai Food and Drug Administration | 18/09/2014 | |
| IMOVAX POLIO | Polio Vaccine - Inactivated (IPV) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 09/12/2005 | |
| IMOVAX dT adult | Diphtheria-Tetanus (reduced antigen content) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 22/07/1997 | |
| IPV Vaccine SSI | Polio Vaccine - Inactivated (IPV) | Vial | AJ Vaccines A/S | Danish Medicines Agency | 23/12/2010 | |
| Inactivated Poliomyelitis Vaccine made from Sabin Strains (Vero Cell) | Polio Vaccine - Inactivated Sabin (sIPV) | Vial | Beijing Institute of Biological Products Co., Ltd. | National Medical Products Administration | 15/02/2022 | - |
| Influenza A (H1N1) 2009 monovalent vaccine | Influenza, Pandemic (H1N1) | Sprayer | MedImmune | CBER/FDA | 25/02/2010 | |
| Influenza A (H1N1) 2009 monovalent vaccine | Influenza, Pandemic (H1N1) | Vial | Sanofi Pasteur Inc. | CBER/FDA | 28/01/2010 | - |
| Influenza Vaccine (Split virion, inactivated) | Influenza, seasonal (Trivalent) | Vial | Hualan Biological Bacterin Inc. | National Medical Products Administration | 09/06/2015 | |
| JEEV® (3µg) | Japanese Encephalitis Vaccine (Inactivated) (3µg Pediatric) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 03/08/2016 | - |
| JEEV® (3µg) | Japanese Encephalitis Vaccine (Inactivated) (3µg Pediatric) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 02/10/2018 | |
| JEEV® (6µg) | Japanese Encephalitis Vaccine (Inactivated) 6µg | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 12/07/2013 | |
| JEEV® (6µg) | Japanese Encephalitis Vaccine (Inactivated) 6µg | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 02/10/2018 | |
| Japanese Encephalitis Vaccine Live (SA14-14-2) | Japanese Encephalitis Vaccine (live, attenuated) | Two vial set (active + excipient) | Chengdu Institute of Biological Products Co.,Ltd | National Medical Products Administration | 08/10/2013 | |
| Japanese Encephalitis Vaccine Live (SA14-14-2) | Japanese Encephalitis Vaccine (live, attenuated) | Two vial set (active + excipient) | Chengdu Institute of Biological Products Co.,Ltd | National Medical Products Administration | 08/10/2013 | |
| Measles Vaccine, Live, Attenuated | Measles | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 15/02/1993 | |
| Measles and Rubella Vaccine (Live) (Attenuated, Freeze Dried) | Measles and Rubella | Vial + Ampoule | Biological E. Limited | Central Drugs Standard Control Organization | 24/09/2019 | |
| Measles and Rubella Vaccine, Live, Attenuated | Measles and Rubella | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 18/07/2000 | |
| Measles vaccine | Measles | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 04/09/2006 | |
| Measles vaccine | Measles | Vial + Ampoule | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 09/04/1997 | |
| Measles, Mumps and Rubella Vaccine, Live, Attenuated | Measles, Mumps and Rubella | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 08/08/2003 | |
| MenQuadfi | Meningococcal ACYW-135 (conjugate vaccine) | Vial | Sanofi Pasteur Inc. | European Medicines Agency | 28/01/2022 | |
| Menactra | Meningococcal ACYW-135 (conjugate vaccine) | Vial | Sanofi Pasteur Inc. | CBER/FDA | 21/03/2014 | |
| Meningococcal A Conjugate 5 micrograms MenAfriVac 5µg | Meningococcal A Conjugate 5 µg | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 30/12/2014 | |
| Meningococcal A Conjugate MenAfriVac | Meningococcal A Conjugate 10 µg | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 23/06/2010 | |
| Menveo | Meningococcal ACYW-135 (conjugate vaccine) | Two vial set (active + active) | GlaxoSmithKline Vaccines S.r.l. | European Medicines Agency | 31/07/2013 | - |
| Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1) | Polio Vaccine - Oral (OPV) Monovalent Type 1 | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 03/11/2009 | |
| Monovalent Oral Poliomyelitis Vaccine Type 2 | Polio Vaccine - Oral (OPV) Monovalent Type 2 | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 21/06/2019 | |
| Monovalent type 1 Oral Poliomyelitis vaccine, IP (mOPV1) | Polio Vaccine - Oral (OPV) Monovalent Type 1 | Vial | Haffkine Bio Pharmaceutical Corporation Ltd | Central Drugs Standard Control Organization | 03/11/2009 | |
| Mosquirix | Plasmodium falciparum (Malaria) and Hepatitis B (recombinant, adjuvanted) | Two vial set (active + active) | GlaxoSmithKline Biologicals SA | European Medicines Agency | 15/07/2022 | - |
| Mvabea | Ebola vaccine (MVA-BN-Filo [recombinant]) | Vial | Janssen Vaccines, Branch of Cilag GmbH International | European Medicines Agency | 27/04/2021 | |
| NASOVAC Influenza Vaccine, Live Attenuated (Human) Freeze-Dried | Influenza, Pandemic (H1N1) | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 26/11/2012 | |
| Nasovac-S Influenza Vaccine, Live, Attenuated (Human) | Influenza, seasonal (Trivalent) | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 30/09/2015 | |
| Nimenrix | Meningococcal ACYW-135 (conjugate vaccine) | Vial + Ampoule | Pfizer Europe MA EEIG | European Medicines Agency | 31/08/2016 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name BE Td | Diphtheria-Tetanus (reduced antigen content) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 17/09/2014 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name BE Td | Diphtheria-Tetanus (reduced antigen content) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 09/03/2020 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name BEtt. | Tetanus Toxoid | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 21/12/2009 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name BEtt. | Tetanus Toxoid | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 12/07/2012 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 18/05/2012 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 27/11/2014 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Reconstituted). | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Two vial set (active + active) | Biological E. Limited | Central Drugs Standard Control Organization | 01/09/2011 | |
| None used on labelling for supply through UN agencies. Also marketed with labelled commercial name TRIPVAC | Diphtheria-Tetanus-Pertussis (whole cell) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 31/07/2014 | |
| OPVERO | Polio Vaccine - Oral (OPV) Trivalent | Vial | Sanofi Pasteur SA | Agence nationale de sécurité du médicament et des produits de santé | 16/06/2002 | |
| ORAL MONOVALENT TYPE 1 POLIOMYELITIS VACCINE | Polio Vaccine - Oral (OPV) Monovalent Type 1 | Vial | Sanofi Pasteur SA | Agence nationale de sécurité du médicament et des produits de santé | 08/05/2008 | |
| ORAL MONOVALENT TYPE 2 POLIOMYELITIS VACCINE (mOPV2) | Polio Vaccine - Oral (OPV) Monovalent Type 2 | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 14/01/2016 | |
| ORAL MONOVALENT TYPE 3 POLIOMYELITIS VACCINE | Polio Vaccine - Oral (OPV) Monovalent Type 3 | Vial | Sanofi Pasteur SA | Agence nationale de sécurité du médicament et des produits de santé | 25/01/2016 | |
| Oral Poliomyelitis Vaccines (Oral Drops) | Polio Vaccine - Oral (OPV) Trivalent | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 31/08/2020 | |
| PNEUMOSIL® | Pneumococcal (conjugate) | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 18/12/2019 | |
| Pandemic Live Attenuated Vaccine | Influenza, Pandemic (Live Attenuated) | Sprayer | AstraZeneca Pharmaceuticals LP. | European Medicines Agency | 18/12/2020 | |
| Panenza | Influenza, Pandemic (H1N1) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 22/01/2010 | |
| Panvax | Influenza, Pandemic (H1N1) | Vial | Seqirus Limited | Therapeutic Goods Administration | 01/12/2009 | |
| Pentabio | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 19/12/2014 | |
| Picovax | Polio Vaccine - Inactivated (IPV) | Vial | AJ Vaccines A/S | Danish Medicines Agency | 21/04/2020 | |
| Polio Sabin Mono T1 | Polio Vaccine - Oral (OPV) Monovalent Type 1 | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 29/10/2009 | |
| Polio Sabin Mono Three (oral) | Polio Vaccine - Oral (OPV) Monovalent Type 3 | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 05/10/2010 | - |
| Polio Sabin Mono Two (oral) | Polio Vaccine - Oral (OPV) Monovalent Type 2 | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 11/05/2011 | |
| Polio Sabin One and Three | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 29/10/2009 | |
| Poliomyelitis Vaccine (Inactivated) | Polio Vaccine - Inactivated (IPV) | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 28/10/2016 | |
| Poliomyelitis Vaccine (Inactivated) | Polio Vaccine - Inactivated (IPV) | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 11/07/2019 | |
| Poliomyelitis Vaccine (Oral), Bivalent types 1 and 3 | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/02/2013 | |
| Poliomyelitis Vaccine (live, oral attenuated, human Diploid Cell), type 1 and 3 | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Beijing Institute of Biological Products Co., Ltd. | National Medical Products Administration | 21/12/2017 | |
| Poliomyelitis vaccine | Polio Vaccine - Inactivated (IPV) | Vial | Bilthoven Biologicals B.V. | Medicines Evaluation Board (MEB) | 06/12/2010 | |
| Poliomyelitis vaccine multidose, suspension for injection 2.5 mL | Polio Vaccine - Inactivated (IPV) | Vial | Bilthoven Biologicals B.V. | Medicines Evaluation Board (MEB) | 28/11/2014 | |
| Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains | Polio Vaccine - Inactivated Sabin (sIPV) | Vial | Sinovac Biotech Co. Ltd | National Medical Products Administration | 06/06/2022 | |
| Poliorix | Polio Vaccine - Inactivated (IPV) | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 05/08/2010 | - |
| Polioviral vaccine | Polio Vaccine - Oral (OPV) Trivalent | Vial | Haffkine Bio Pharmaceutical Corporation Ltd | Central Drugs Standard Control Organization | 02/02/2006 | |
| Prevenar 13 | Pneumococcal (conjugate) | Vial | Pfizer Europe MA EEIG | European Medicines Agency | 20/08/2010 | |
| Prevenar 13 Multidose Vial | Pneumococcal (conjugate) | Vial | Pfizer Europe MA EEIG | European Medicines Agency | 14/07/2016 | |
| Priorix | Measles, Mumps and Rubella | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 21/12/2011 | |
| Priorix | Measles, Mumps and Rubella | Vial | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 09/03/2001 | |
| Quimi-Hib | Haemophilus influenzae type b | Vial | Centro de Ingenieria Genetica y Biotecnologia | Centro para el Control Estatal de la Calidad de los Medicamentos | 26/04/2010 | - |
| ROTASIIL | Rotavirus (live, attenuated) | Two vial set (active + excipient) | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 21/09/2018 | |
| ROTASIIL-Liquid | Rotavirus (live, attenuated) | Plastic Tube | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 18/02/2021 | |
| ROTASIIL®Thermo | Rotavirus (live, attenuated) | Two vial set (active + excipient) | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 28/01/2020 | |
| ROTAVAC 5D® | Rotavirus (live, attenuated) | Vial | Bharat Biotech International Limited | Central Drugs Standard Control Organization | 18/06/2021 | |
| Rabies Vaccine Inactivated (Freeze Dried)(RABIVAX-S) | Rabies | Vial + Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 20/12/2018 | |
| Rabipur | Rabies | Vial | Chiron Behring Vaccines Private Ltd. | Central Drugs Standard Control Organization | 10/04/2018 | |
| Rotarix | Rotavirus | Applicator | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 12/03/2009 | |
| Rotarix | Rotavirus | Plastic Tube | GlaxoSmithKline Biologicals SA | Federal Agency for Medicinal and Health Products | 14/02/2019 | |
| Rotarix | Rotavirus | Plastic Tube | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | 12/03/2009 | |
| Rotateq | Rotavirus | Plastic Tube | Merck Vaccines | CBER/FDA | 07/10/2008 | |
| Rotavac | Rotavirus (live, attenuated) | Vial | Bharat Biotech International Limited | Central Drugs Standard Control Organization | 05/01/2018 | |
| Rubella Vaccine, Live, Attenuated | Rubella | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 01/09/2006 | |
| SKYCellflu Quadrivalent Multi inj. | Influenza, seasonal (Quadrivalent) | Vial | SK Bioscience Co., Ltd. | Ministry of Food and Drug Safety | 27/12/2019 | |
| SKYCellflu Quadrivalent inj. | Influenza, seasonal (Quadrivalent) | Vial | SK Bioscience Co., Ltd. | Ministry of Food and Drug Safety | 27/12/2019 | |
| SKYCellflu® Multi inj. | Influenza, seasonal (Trivalent) | Vial | SK Bioscience Co., Ltd. | Ministry of Food and Drug Safety | 08/04/2019 | |
| SKYCellflu® inj. | Influenza, seasonal (Trivalent) | Vial | SK Bioscience Co., Ltd. | Ministry of Food and Drug Safety | 15/05/2019 | |
| SKYVaricella Inj. | Varicella | Two vial set (active + excipient) | SK Bioscience Co., Ltd. | Ministry of Food and Drug Safety | 09/12/2019 | |
| STAMARIL | Yellow Fever | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 01/01/1987 | |
| Serinflu | Influenza, seasonal (Trivalent) | Vial | Abbott Biologicals BV | Medicines Evaluation Board (MEB) | 25/05/2018 | |
| Shan-5 | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Vial | Sanofi Healthcare India Private Limited | Central Drugs Standard Control Organization | 29/04/2014 | |
| ShanIPV | Polio Vaccine - Inactivated (IPV) | Vial | Sanofi Healthcare India Private Limited | Central Drugs Standard Control Organization | 01/10/2018 | |
| ShanTT | Tetanus Toxoid | Vial | Sanofi Healthcare India Private Limited | Central Drugs Standard Control Organization | 30/08/2007 | |
| Shanchol | cholera: inactivated oral | Vial | Sanofi Healthcare India Private Limited | Central Drugs Standard Control Organization | 29/09/2011 | |
| Stabilized Yellow Fever Vaccine | Yellow Fever | Vial | Institut Pasteur de Dakar | Ministère de la Santé publique | 20/03/2001 | |
| Synflorix | Pneumococcal (conjugate) | Vial | GlaxoSmithKline Biologicals SA | European Medicines Agency | 16/10/2017 | |
| TETAVAX | Tetanus Toxoid | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 22/07/1997 | |
| TT vaccine | Tetanus Toxoid | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 11/03/1999 | |
| TT vaccine | Tetanus Toxoid | Uniject | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 29/10/2003 | |
| TYPHIBEV® | Typhoid (Conjugate) | Vial | Biological E. Limited | Central Drugs Standard Control Organization | 04/12/2020 | |
| TYPHIM Vi | Typhoid (Polysaccharide) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 01/06/2011 | |
| Tetadif | Diphtheria-Tetanus (reduced antigen content) | Vial | BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.) | Bulgarian Drug Agency | 09/05/2006 | |
| Tetanus Toxoid Vaccine Adsorbed | Tetanus Toxoid | Ampoule | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Tetanus Toxoid Vaccine Adsorbed | Tetanus Toxoid | Vial | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | 04/04/1995 | |
| Tetatox | Tetanus Toxoid | Vial | BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.) | Bulgarian Drug Agency | 09/05/2006 | |
| Typbar-TCV | Typhoid (Conjugate) | Vial | Bharat Biotech International Limited | Central Drugs Standard Control Organization | 22/12/2017 | |
| VERORAB | Rabies | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 22/06/2005 | |
| Varivax | Varicella | Two vial set (active + excipient) | Merck Vaccines | CBER/FDA | 09/02/2018 | |
| VaxiRab N | Rabies | Vial | Cadila Health Care Ltd | Central Drugs Standard Control Organization | 06/02/2019 | |
| Vaxigrip | Influenza, seasonal (Trivalent) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 30/06/2011 | |
| VaxigripTetra | Influenza, seasonal (Quadrivalent) | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 15/10/2020 | - |
| Yellow Fever | Yellow Fever | Two vial set (active + excipient) | Bio-Manguinhos/Fiocruz | Agencia Nacional da Vigilancia Sanitaria | 17/10/2001 | |
| Yellow Fever | Yellow Fever | Two vial set (active + excipient) | Bio-Manguinhos/Fiocruz | Agencia Nacional da Vigilancia Sanitaria | 10/12/2007 | |
| Yellow Fever | Yellow Fever | Two vial set (active + excipient) | Bio-Manguinhos/Fiocruz | Agencia Nacional da Vigilancia Sanitaria | 17/10/2001 | |
| Zabdeno | Ebola vaccine (Ad26.ZEBOV-GP [recombinant]) | Vial | Janssen Vaccines, Branch of Cilag GmbH International | European Medicines Agency | 27/04/2021 | |
| influenza trivalent vaccine (split virion, inactivated) | Influenza, seasonal (Trivalent) | Vial | Instituto Butantan | Agencia Nacional da Vigilancia Sanitaria | 26/04/2021 | |
| none | Diphtheria-Tetanus (reduced antigen content) | Vial | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | 06/07/2011 | |
| none | Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Vial | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | 02/08/2011 | |
| rHA M-M-R II | Measles, Mumps and Rubella | Vial | Merck Vaccines | European Medicines Agency | 06/01/2009 | |
Copyright © 2009-2023 Global Health Press Pte Ltd. Reg. No. 200921795N All Rights Reserved.
Subject to Creative Commons Licence (cc).
